These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6222351)

  • 21. [Myoclonic bismuth-induced encephalopathy. Case report (author's transl)].
    Loseke N; Retif J; Coune A; Soebert A; Molle L; D'haens J
    Acta Gastroenterol Belg; 1978; 41(1-2):72-80. PubMed ID: 665114
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bismuth myoclonic encephalopathy. Report of two cases (author's transl)].
    Cervelló MA; Alfaro A; Antolín MA; Peñarrocha M
    Med Clin (Barc); 1982 Jul 1-31; 79(3):137-40. PubMed ID: 7109770
    [No Abstract]   [Full Text] [Related]  

  • 23. Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants.
    Mura P; Kintz P; Robert R; Papet Y
    J Anal Toxicol; 1998; 22(3):254. PubMed ID: 9602946
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myoclonic encephalopathy caused by propafenone].
    Jeandel C; Bannwarth B; Trechot P; Barroche G; Penin F; Cuny G
    Therapie; 1990; 45(2):161-2. PubMed ID: 2353331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J; Mason M; Dairou R
    Nouv Presse Med; 1974 Dec; 3(44):2662. PubMed ID: 4459861
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute buflomedil intoxication: a life-threatening condition.
    Alberti A; Valenti S; Gallo F; Petolillo M; Del Monte D
    Intensive Care Med; 1994; 20(3):219-21. PubMed ID: 8014291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polygraphic study of bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Tassinari CA; Terzano G; Picornell I
    Rev Electroencephalogr Neurophysiol Clin; 1975; 5(3):295-302. PubMed ID: 1230925
    [No Abstract]   [Full Text] [Related]  

  • 32. Encephalopathy with myoclonic jerks resulting from ceftazidime therapy: an under-recognized potential side-effect when treating febrile neutropenia.
    Martin MG
    Leuk Lymphoma; 2007 Feb; 48(2):413-4. PubMed ID: 17325906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute fatal poisoning with buflomedil].
    Danel V; Saviuc P; Vincent F; Barret L; Debru JL
    J Toxicol Clin Exp; 1988; 8(4):243-6. PubMed ID: 3216338
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myoclonic coma and severe cardiac insufficiency in a patient with arteritis].
    Blain H; Jeandel C
    Rev Med Interne; 2001 Jun; 22 Suppl 2():247s-249s. PubMed ID: 11433584
    [No Abstract]   [Full Text] [Related]  

  • 35. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bismuth encephalopathy. A propos of 2 cases].
    Loutre JC; Viguié R; Kunstler E; Nehlil J
    Rev Neurol (Paris); 1975 Dec; 131(12):883-6. PubMed ID: 1232663
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Reversible acute myoclonic encephalopathies after bismuth salt ingestion].
    Fressinaud L; Emile J; Charbonnel A; Féve JR
    Nouv Presse Med; 1975 Mar; 4(12):885. PubMed ID: 1136684
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G
    Therapie; 1980; 35(3):305-6. PubMed ID: 6775384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.